Monday, August 26, 2019 10:35:17 AM
Vireo Health Affiliate Given Green Light to Operate Medical Cannabis Processing Facility in Ohio
https://www.prnewswire.com/news-releases/vireo-health-affiliate-given-green-light-to-operate-medical-cannabis-processing-facility-in-ohio-300902399.html
MINNEAPOLIS, Aug. 15, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO,OTCQX: VREOF), a leading physician-led, science-focused multi-state cannabis company, today announced that the Company's affiliate, Ohio Medical Solutions ("OMS"), was granted a Certificate of Operation by the Ohio Department of Commerce. OMS, which will begin operating immediately, was previously awarded a provisional processing license.
OMS is now permitted to purchase plant material from licensed cultivators, manufacture a wide variety of Vireo-branded pharmaceutical-grade cannabis products, and wholesale these products to third-party dispensaries throughout the state of Ohio.
"We are delighted that Ohio Medical Solutions will begin manufacturing Vireo products for the benefit of Ohio patients," said Chief Executive Officer, Kyle Kingsley, M.D. "The City of Akron has been great to us and as our business grows, we look forward to continuing to create new jobs and make a positive impact on the local economy."
Located in a former factory building that had fallen into disuse and disrepair, the Company's 11,500 square-foot facility, in Akron, Ohio has been transformed, through a multi-million-dollar investment, into a state-of-the-art pharmaceutical manufacturing facility. The renovated facility features new building systems, a new roof, complete interior redesign, and the installation of a best-in-class security system and fence.
"I am honored to serve as General Manager and lead this facility," said Marie Walchalk, OMS General Manager. "As a life-long Ohioan I have personally witnessed too many manufacturing jobs leave our State and it's great to be part of an industry adding new good-paying local jobs."
Ohio's Medical Marijuana Bill (HB 523) was signed into law on June 8, 2016 by Governor Kasich. The State's medical marijuana program is rapidly expanding. Sales of medical marijuana officially began on January 16, 2019. There are now 527 certified physicians and 25 active dispensaries serving the State's 53,082 registered patients and almost 4,000 registered caregivers.
About Vireo Health International, Inc.
Vireo Health International, Inc.'s mission is to build the cannabis company of the future by bringing the best of medicine, engineering and science to the cannabis industry. Vireo's physician-led team of more than 300 employees provides best-in-class cannabis products and customer experience. Vireo cultivates cannabis in environmentally friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third-party dispensaries. The Company currently is licensed in eleven markets including Arizona, Maryland, Massachusetts, Minnesota, New Mexico, New York, Nevada, Ohio, Pennsylvania, Puerto Rico, and Rhode Island. For more information about the company, please visit www.vireohealth.com.
Recent GDNSF News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/04/2024 01:25:11 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/11/2024 08:06:53 PM
- Form SCHEDULE 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/19/2024 04:19:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 09:06:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 07:41:04 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/12/2023 08:31:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 08:30:39 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/07/2023 09:57:08 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/07/2023 09:54:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/07/2023 09:53:11 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/07/2023 09:51:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:15:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 05:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:02:29 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/22/2023 07:41:50 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/15/2023 10:01:55 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:45:39 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/11/2023 08:54:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 05:06:24 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 08/10/2023 10:04:50 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 08/04/2023 08:31:30 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM